1.
Autier, PBM, Pizot, C & Mullie, P (2013) Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol
2, 76–89.
2.
Bolland, MJ, Grey, A, Gamble, GD
et al. (2014) The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol
2, 307–320.
3.
Anon. (2014) Vitamin D: chasing a myth? (editorial). Lancet Diabetes Endocrinol
2, 1.
4.
Hossein-Nezhad, A & Holick, MF (2006) Vitamin D for health: global perspsective. Mayo Clin Proc
81, 353–373.
5.
Anon. (2014) Further doubt cast on benefit of vitamin D supplementation for disease prevention. Press release promoting Autier et al. (2013); available at http://www.thelancet.com/press-room
6.
Anon. (2014) New analysis suggests that further trials of vitamin D have little chance of showing health benefits. Press release promoting Bolland et al. (2014); available at http://www.thelancet.com/press-room
7.
Heaney, R (2014) Some guidelines for design and analysis of clinical studies of nutrient effects. Nutr Rev
72, 48–54.
8.
Holick, MF (2006) Resurrection of vitamin D deficiency and rickets. J Clin Invest
116, 2062–2072.
9.
Barker, DJ & Gardner, MJ (1974) Distribution of Paget’s disease in England, Wales and Scotland and a possible relationship with vitamin D deficiency in childhood. Br J Prev Soc Med
28, 226–232.
10.
Guillard-Cumming, DF, Beard, DJ, Douglas, DL
et al. (1985) Abnormal vitamin D metabolism in Paget’s disease of bone. Clin Endocrinol (Oxf)
22, 559–566.
11.
Reddy, SV (2004) Etiology of Paget’s disease and osteoclast abnormalities. J Cell Biochem
93, 688–696.
12.
Perry, D (2013) Unravelling the enigma of Perthes’ disease. Ann R Coll Surg Engl
95, 311–316.
13.
Ameri, P, Canepa, M, Milaneschi, Y
et al. (2013) Relationship between vitamin D status and left ventricular geometry in a healthy population: results from the Baltimore Longitudinal Study of Aging. J Intern Med
273, 253–262.
14.
Assalin, HB, Rafacho, BP, dos Santos, PP
et al. (2013) Impact of the length of vitamin D deficiency on cardiac remodeling. Circ Heart Fail
6, 809–816.
15.
Zheng, Y, Zhu, J, Zhou, M
et al. (2013) Meta-analysis of long-term vitamin D supplementation on overall mortality. PLoS One
8, e82109.
16.
Łuczyńska, A, Kaaks, R, Rohrmann, S
et al. (2013) Plasma 25-hydroxyvitamin D concentration and lymphoma risk: results of the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr
98, 827–838.
17.
Ottaggio, L, Zunino, A, Maric, I
et al. (2008) The presence of high-risk chromosome aberrations in chronic lymphocytic leukaemia does not correlate with centrosome aberrations. Hematol Oncol Clin North Am
26, 39–42.
18.
Pepper, C, Thomas, A, Hoy, T
et al. (2003) The vitamin D3 analog EB1089 induces apoptosis via a p53-independent mechanism involving p38 MAP kinase activation and suppression of ERK activity in B-cell chronic lymphocytic leukemia cells in vitro
. Blood
101, 2454–2460.
19.
Pierrot-Deseilligny, C & Sounerbielle, JC (2013) Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis. Ther Adv Neurol Disord
6, 81–116.
20.
DeLuca, GC, Kolasinski, J, Ramagopalan, SV
et al. (2013) Review: the role of vitamin D in nervous system health and disease. Neuropathol Appl Neurobiol
39, 458–484.
21.
Tulic, MK, Andrews, D, Crook, ML
et al. (2012) Changes in thymic regulatory T-cell maturation from birth to puberty: differences in atopic children. J Allergy Clin Immunol
129, 199–206.
22.
Ramagopalan, SV, Maugeri, NJ, Handunnetthi, L
et al. (2009) Expression of the multiple sclerosis-associated MHC class II allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet
5, e1000369.
23.
Derakhshandi, H, Etemadifar, M, Feizi, A
et al. (2013) Preventive effect of vitamin D3 supplementation on conversion of optic neuritis to clinically definite multiple sclerosis: a double blind, randomized, placebo-controlled pilot clinical trial. Acta Neurol Belg
113, 257–263.
24.
Ramagopalan, SV, Maugeri, NJ, Handunnetthi, L
et al. (2013) Hospital admissions for vitamin D related conditions and subsequent immune-mediated disease: record-linkage studies. BMC Med
11, 171.
25.
Disanto, G, Chaplin, G, Morahan, JM
et al. (2012) Month of birth, vitamin D and risk of immune mediated disease: a case control study. BMC Med
10, 69.
26.
Disanto, G, Morahan, JM, Lacey, MV
et al. (2012) Seasonal distribution of psychiatric births in England. PLoS One
7, e34866.
27.
Grant, WB & Soles, CM (2009) Epidemiologic evidence supporting the role of maternal vitamin D deficiency as a risk factor for the development of infantile autism. Dermato-endocrinology
1, 223–228.
28.
Gibney, SM & Drexhage, HA (2013) Evidence for a dysregulated immune system in the etiology of psychiatric disorders. J Neuroimmune Pharmacol
8, 900–920.
29.
Boucher, B (2011) Vitamin D insufficiency and diabetes risks. Current Drug Targets
12, 61–87.
30.
Hypponen, E, Laara, E, Reunanen, A
et al. (2001) Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet
358, 1500–1503.
31.
Byar, DP, Simon, RM, Friedewald, WT
et al. (1976) Randomized clinical trials. Perspectives on some recent ideas. N Engl J Med
95, 74–80.
32.
Ross, A, Manson, J, Abrams, S
et al. (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab
96, 53–58.
33.
Holick, MF, Binkley, NC, Bischoff-Ferrari, HA
et al. (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab
96, 1911–1930.
34.
Pilz, S, Tomaschitz, A, Drechsler, M
et al. (2011) Vitamin D, cardiovascular disease and mortality. Clin Endocrinol (Oxf)
75, 575–584.
35.
Zittermann, A, Gummert, JF & Borgermann, J (2009) Vitamin D deficiency and mortality. Curr Opin Clin Nutr Metab Care
12, 634–639.
36.
Zittermann, A & Grant, WB (2009) 25-Hydroxyvitamin D levels and all-cause mortality. Arch Intern Med
169, 1075–1076, author reply 1076.
37.
Autier, P & Gandini, S (2007) Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med
167, 1730–1737.
38.
Grant, W (2011) An estimate of the global reduction in mortality rates through doubling vitamin D levels. Eur J Clin Nutr
65, 1016–1026.
39.
Coussens, AK, Wilkinson, RA, Hanifa, Y
et al. (2012) Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proc Natl Acad Sci USA
109, 15449–15454.
40.
Martineau, A (2013) Vitamin D: an adjunct to antiretroviral therapy?
J Infect Dis
207, 373–375.
41.
Camargo, CA Jr, Ganmas, D, Lindsay Frazier, A
et al. (2012) Randomized trial of vitamin D supplementation and risk of acute respiratory tract infection in Mongolia. Pediatrics
130, 561–567.
42.
Urashima, M, Segawa, T, Okazaki, M
et al. (2010) Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr
91, 1255–1260.
43.
Berlanga-Taylor, A & Ramagopalan, S (2013) Vitamin D and multiple sclerosis: what is the clinial impact?
Expert Opin Diagn
7, 227–229.
44.
Aghajafari, F, Nagulesapillai, T, Ronksley, P
et al. (2013) Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies. BMJ
346, f1169.